Transglutaminase 2 Inhibition Reverses Mesenchymal Transdifferentiation of Glioma Stem Cells by Regulating C/EBPβ Signaling
Necrosis is a hallmark of glioblastoma (GBM) and is responsible for poor prognosis and resistance to conventional therapies. However, the molecular mechanisms underlying necrotic microenvironment-induced malignancy of GBM have not been elucidated. Here, we report that transglutaminase 2 (TGM2) is up...
Сохранить в:
Главные авторы: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Формат: | Artigo |
Язык: | английский |
Опубликовано: |
2017
|
Online-ссылка: | https://doi.org/10.1158/0008-5472.can-17-0388 |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|